a public good project by the
Synthesis
Company
of California

© 2026

Jun Wu | doi.page

0 works0 citations0 h-index

Jun Wu

Memorial Hospital of South Bend(US)Washington University in St. Louis(US)Third Affiliated Hospital of Southern Medical University(CN)Zhujiang Hospital(CN)Northern Jiangsu People's Hospital(CN)Southern Medical University(CN)Yangzhou University(CN)

Publications by Year

Research Areas

Nanoparticle-Based Drug Delivery, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Immunotherapy and Immune Responses, Ferroptosis and cancer prognosis

Most-Cited Works

→ Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer(2021)112 cited
→ Molecular Cloning and Characterization of Human JNKK2, a Novel Jun NH₂-Terminal Kinase-Specific Kinase(1997)107 cited
→ The rice retrotransposon Tos17 prefers low-copy-number sequences as integration targets(2001)96 cited
→ Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity(2021)77 cited
→ Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer(2019)59 cited
→ Emerging immune checkpoints for cancer therapy(2015)55 cited

→ P2Y₂receptor of MDCK cells: cloning, expression, and cell-specific signaling(2000)

33 cited

→ Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis(2018)26 cited

→ SChLAP1 contributes to non-small cell lung cancer cell progression and immune evasion through regulating the AUF1/PD-L1 axis(2021)20 cited

→ MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells(2019)18 cited